Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03427177 · ClinicalTrials.gov registry record · NA

Mychoice: Testing an Interactive mHealth Tool

A NA study, sponsored by Fox Chase Cancer Center.

Completed
Registry status
NA
Development phase
257
Enrollment target

NCT03427177: Completed NA study, sponsored by Fox Chase Cancer Center.

NCT03427177 is a NA study that has completed, run by Fox Chase Cancer Center. The registered enrollment target is 257 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03427177, a NA study, has completed, sponsored by Fox Chase Cancer Center.

COMPLETED
Registry status
NA
Development phase
257 participants
Enrollment target

Study Summary

Investigators aim to test a culturally diverse and patient guided mHealth decision tool called mychoice, which allows patients to explore their concerns and questions related to clinical trial participation, as well as create a customized and personalized set of questions to enhance patient-provider communication and increase informed decision making. This study employs a mixed-methods approach using both qualitative and quantitative data to evaluate the effectiveness of the mychoice intervention for patients and to explore the provider and organizational factors that impact implementation. A randomized controlled trial will be performed with 270 participants in order to determine the acceptability and feasibility of the intervention, as well as its effects on self-efficacy in discussing clinical trial participation with providers, leading to enhanced informed decision-making. A secondary aim of the study is to evaluate the implementation of the intervention in clinical settings. Implementation evaluation will occur using surveys of medical staff whose patients are participating in the study. These surveys will assess institutional facilitators and barriers to study implementation. Investigators will also conduct cognitive de-briefing interviews after the intervention is completed with key stakeholders at the participating institutions, which will inform a larger implementation study in the future.

Primary Outcome

10-item scale measuring patient confidence in communicating with their physician. Participants respond to each question on a scale of 1 to 5, with 5 representing "very confident,'' and 1 representing "not at all confident." The range of possible scores for the full PEPPI scale is 10 to 50 (50 representing highest patient-perceived self-efficacy).

Interventions

  • BEHAVIORAL mychoice

Trial Details

FieldValue
Enrollment Target 257 participants
Start Date 2018-06-25
Est. Completion 2020-02-28
Phase NA
Fox Chase Cancer Center

183 total trials

What the finished NCT03427177 record still lists

NCT03427177 is an interventional study that assigns participants to a tested intervention. The registered 257 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower).

The record links to 0 conditions, and to 1 intervention - of which mychoice is the first listed.

NCT03427177 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03427177 about?

NCT03427177 is a clinical study titled "Mychoice: Testing an Interactive mHealth Tool". Investigators aim to test a culturally diverse and patient guided mHealth decision tool called mychoice, which allows patients to explore their concerns and questions related to clinical trial participation, as well as create a customized and personalized set of questions to enhance patient-provider...

What is the current status of trial NCT03427177?

This trial is currently completed. It is a NA study. The enrollment target is 257 participants. The study started on 2018-06-25. Estimated completion is 2020-02-28.

What interventions are being tested in trial NCT03427177?

The interventions under investigation include: mychoice (BEHAVIORAL).

Who is sponsoring clinical trial NCT03427177?

This trial is sponsored by Fox Chase Cancer Center, which has 183 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03427177's enrollment target sits among peer trials

257 403rd of 2000 higher than 1,597 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03618550 · 257 participants · Phase 2

    Phase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin Lymphoma

  • NCT04674267 · 257 participants · NA

    Resilience and Equity in Aging, Cancer, and Health (REACH)

  • NCT06099288 · 257 participants · NA

    Strong Families Start at Home/Familias Fuertes Comienzan en Casa

  • NCT06207084 · 257 participants · NA

    The Fit With Us Study

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03427177, the US trial registry maintained by the National Library of Medicine. NCT03427177 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.